Seaward Management Limited Partnership maintained its position in Aetna Inc. (NYSE:AET) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,330 shares of the company’s stock at the end of the second quarter. Seaward Management Limited Partnership’s holdings in Aetna were worth $2,327,000 at the end of the most recent reporting period.
A number of other institutional investors have also bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. raised its position in Aetna by 31.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 52,641 shares of the company’s stock worth $6,713,000 after buying an additional 12,648 shares in the last quarter. Columbus Circle Investors raised its position in Aetna by 358.8% in the first quarter. Columbus Circle Investors now owns 51,831 shares of the company’s stock worth $6,611,000 after buying an additional 40,535 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Aetna by 0.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 282,165 shares of the company’s stock worth $35,990,000 after buying an additional 875 shares in the last quarter. Toronto Dominion Bank raised its position in Aetna by 57.0% in the first quarter. Toronto Dominion Bank now owns 95,608 shares of the company’s stock worth $12,194,000 after buying an additional 34,719 shares in the last quarter. Finally, Boston Advisors LLC raised its position in Aetna by 20.8% in the first quarter. Boston Advisors LLC now owns 2,906 shares of the company’s stock worth $371,000 after buying an additional 500 shares in the last quarter. 91.73% of the stock is currently owned by institutional investors.
Shares of Aetna Inc. (NYSE:AET) opened at 152.42 on Friday. The firm has a 50 day moving average price of $154.28 and a 200 day moving average price of $138.79. The company has a market capitalization of $50.62 billion, a P/E ratio of 33.83 and a beta of 0.54. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69.
Aetna (NYSE:AET) last announced its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the business earned $2.21 EPS. On average, equities research analysts predict that Aetna Inc. will post $9.46 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Thursday, July 13th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.31%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s payout ratio is presently 43.67%.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.com-unik.info/2017/08/11/seaward-management-limited-partnership-has-2327000-stake-in-aetna-inc-nyseaet.html.
AET has been the topic of a number of recent analyst reports. Royal Bank Of Canada reissued a “buy” rating and issued a $145.00 price objective on shares of Aetna in a research note on Monday, April 24th. Bank of America Corporation reaffirmed a “buy” rating and set a $168.00 price target (up previously from $160.00) on shares of Aetna in a research note on Wednesday, May 17th. Morgan Stanley initiated coverage on Aetna in a research note on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price target on the stock. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $170.00 price target on the stock in a research note on Tuesday, July 4th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $163.00 price target (up previously from $157.00) on shares of Aetna in a research note on Friday, August 4th. Eight equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $157.09.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the transaction, the chairman now directly owns 659,888 shares in the company, valued at $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.